L. Mary Smith, Chief Development Officer at SpringWorks Therapeutics, Inc. (SWTX), sold 10,000 shares at $78.70 ($787K) on 2021-01-20, disclosed to the SEC on 2021-01-21.
Open-market sale of $787k SWTX by Chief Development Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| SWTX | SELL | 2021-04-13 | $1.4M | — | Filing → |